期刊文献+

HIV-1自然感染中的中和抗体反应 被引量:2

Neutralizing antibodies responses during natural HIV-1 infection
原文传递
导出
摘要 中和抗体(Nab)可以防止I型人类免疫缺陷病毒(HIV-1)侵入靶细胞。HIV-1感染数周后即可诱导产生Nab,这些早期抗体只能特异性地中和自体病毒但不能中和异源性病毒。在一些慢性感染者体内则可以检测到可同时中和同源性和异源性病毒的广谱中和抗体(BNab)。BNab的靶点通常位于包膜蛋白的保守区域。HIV-1BNab的产生还受到病毒变异及结构遮盖等因素的限制,同时Nab的中和广度与病毒载量具有相关性。 Neutralizing antibodies can protect a host against the infection by human immunodefi'ciency virus type 1 ( HIV-1 ). Neutralizing antibodies can be induced several weeks after infection. However, the antibodies induced in the early stage can neutralize only the autologous but not heterologous viruses. Nevertheless, broad neutralizing antibodies, which can neutralize both autologous and heterologous viruses, have been found in some chronic patients. Inaddition, broad neutralizing antibodies usually target the conserved regions of HIV-1 envelope glycoprotein. However, the envelope glycoprotein mutation and its structure shielding limit the induction of these antibodies.
出处 《国际免疫学杂志》 CAS 2012年第3期176-179,共4页 International Journal of Immunology
基金 十一五传染病重大专项(2008ZX10001-012),国家自然基金(30771910)
关键词 I型人类免疫缺陷病毒 中和抗体 广谱中和抗体 Human immunodeficiency virus type 1 Neutralizing antibody Broad neutralizing antibody
  • 相关文献

参考文献28

  • 1Tomaras GD, Yates NL, Liu P, et al. Initial B-cell responses to transmitted human immunodeficieney virus type 1 : virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J Virol, 2008, 82(24) : 12449-12463.
  • 2Gray ES, Moore PL, Choge IA, et al. Neutralizing antibody re- sponses in acute human immunodeficiency virus type 1 subtype C infection. J Virol, 2007, 81(12) : 6187-6196.
  • 3Davis KL, Gray ES, Moore PL, et al. High titer HIV-1 V3-specif- ie antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination. Virology, 2009, 387 (2) : 414-426.
  • 4Moore PL, Ranchobe N, Lambson BE, et al. Limited neutralizing antibody specificities drive neutralization escape i~ early HIV-1 subtype C infection. PLoS Pathog, 2009, 5(9) : e1000595.
  • 5Lynch RM, Rong R, Boliar S, et al. The B cell response is re- dundant and highly focused on V1 V2 during early subtype C infec- tion in a Zambian seroconverter. J Virol 2011, 85 (2) : 905-915.
  • 6Moore PL, Gray ES, Choge IA, et al. The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodefi- ciency virus type 1 subtype C infection. J Virol, 2008, 82 (4) : 1860-1869.
  • 7Mikell I, Sather DN, Kalams SA, et al. Characteristics of the ear- liest cross-neutralizing antibody response to HIV-1. PLoS Pathog, 2011, 7(1) : e1001251.
  • 8van Gils M J, Euler Z, Schweighardt B, et al. Prevalence of cross- reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression. AIDS, 2009, 23 (18) : 2405- 2414.
  • 9Euler Z, van Gils M J, Bunnik EM, et al. Cross-Reactive Neutral- izing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression. J Infect Dis 2010; 201(7) : 1045-1053.
  • 10Walker LM, Phogat SK, Chan-Hui PY et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science,2009, 326 (5950) : 285-289.

同被引文献18

  • 1Wu F,Ourmanov I,Kuwata T. Sequential evolution and escape from neutralization of simian immunodeficiency virus SIVsmE660 clones in rhesus macaques[J].{H}Journal of Virology,2012,(16):8835-8847.
  • 2Smith SA,Wood C,West JT. HIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscape[J].PLoS One,2013,(4):e63094.
  • 3Riddle TM,Shire N J,Sherman MS. Sequential turnover of human immunodeficiency virus type 1 env throughout the course of infection[J].{H}Journal of Virology,2006,(21):10591-10599.
  • 4Archary D,Gordon ML,Green TN. HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression[J].{H}RETROVIROLOGY,2010.92.
  • 5Wu F,Ourmanov I,Kuwata T. Sequential evolution and escape from neutralization of simian immunodeficiency virus SIVsmE660 clones in rhesus macaques[J].{H}Journal of Virology,2012,(16):8835-8847.
  • 6Yeh WW,Brassard LM,Miller CA. Envelope variable region 4 is the first target of neutralizing antibodies in early simian immunodeficiency virus mac251 infection of rhesus monkeys[J].{H}Journal of Virology,2012,(13):7052-7059.
  • 7Castro E,Belair M,Rizzardi GP. Independent evolution of hypervariable regions of HIV-1 gp120:V4 as a swarm of N-Linked glycosylation variants[J].{H}AIDS Research and Human Retroviruses,2008,(1):106-113.
  • 8Wang W,Nie J,Prochnow C. A systematic study of the Nglycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization[J].{H}RETROVIROLOGY,2013.14.
  • 9Moore PL,Gray ES,Choge IA. The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection[J].{H}Journal of Virology,2008,(4):1860-1869.
  • 10Belair M,Dovat M,Foley B. The polymorphic nature of HIV type 1 env V4 affects the patterns of potential N-glycosylation sites in proviral DNA at the intrahost level[J].{H}AIDS Research and Human Retroviruses,2009,(2):199-206.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部